Assuntos
Falso Aneurisma/diagnóstico por imagem , Falso Aneurisma/cirurgia , Artérias Temporais/diagnóstico por imagem , Artérias Temporais/cirurgia , Adulto , Procedimentos Cirúrgicos Ambulatórios , Anestesia Local , Erros de Diagnóstico , Cisto Epidérmico/diagnóstico , Traumatismos Cranianos Fechados/complicações , Humanos , Ultrassonografia Doppler em Cores , Ultrassonografia Doppler DuplaAssuntos
Carcinoma de Células Escamosas/secundário , Linfonodos/cirurgia , Retalho Miocutâneo , Terapia de Salvação , Úlcera Cutânea/cirurgia , Neoplasias do Colo do Útero/patologia , Infecções por Escherichia coli/complicações , Feminino , Humanos , Canal Inguinal , Linfonodos/patologia , Metástase Linfática , Reto do Abdome , Úlcera Cutânea/etiologia , Deiscência da Ferida Operatória/complicações , Infecção da Ferida Cirúrgica/complicaçõesRESUMO
The Achilles tendon (AT) is the most frequently ruptured tendon in the human body yet the aetiology remains poorly understood. Despite the extensively published literature, controversy still surrounds the optimum treatment of complete rupture. Both non-operative management and percutaneous repair are attractive alternatives to open surgery, which carries the highest complication and cost profile. However, the lack of a universally accepted scoring system has limited any evaluation of treatment options. A typical UK district general hospital treats approximately 3 cases of AT rupture a month. It is therefore important for orthopaedic surgeons to correctly diagnose and treat these injuries with respect to the best current evidence-based practice. In this review article, we discuss the relevant pathophysiology and diagnosis of the ruptured AT and summarize the current evidence for treatment.
Assuntos
Tendão do Calcâneo/lesões , Tendão do Calcâneo/cirurgia , Tendão do Calcâneo/patologia , Tendão do Calcâneo/fisiopatologia , Medicina Baseada em Evidências , Humanos , Equipamentos Ortopédicos , Procedimentos Ortopédicos , Fatores de Risco , Ruptura/cirurgia , Resultado do TratamentoRESUMO
From the stem bark of Uvaria accuminata two new compounds, 5-methoxy-6,8,8-trimethyl-2-phenylchromene-4,7-dione (1) and a sesquiterpene-fused flavone, named acuminavone (2), were isolated together with a known flavone, desmosdomutin or dasytrichone, (5-hydroxy-6,8,8-trimethyl-2-phenylchromene-4,7-dione). The structure elucidation of compounds 1 and 2 in spectroscopic studies is described.
Assuntos
Flavonas/isolamento & purificação , Uvaria/química , Flavonas/química , Espectroscopia de Ressonância Magnética , Modelos Moleculares , Estrutura Molecular , Análise EspectralRESUMO
The fascaplysin class of compounds have been further investigated from six organisms consisting of four sponge collections (Fascaplysinopsis reticulata) and two tunicate collections (Didemnum sp.). This work is an extension of an earlier communication and reports the isolation of 12 new fascaplysin derivatives: 10-bromofascaplysin (7), 3,10-dibromofascaplysin (8), homofascaplysate A (9), homofascaplysin B-1 (11), 3-bromohomofascaplysins B (12), B-1 (13), and C (15), 7,14-dibromoreticulatine (17), reticulatol (20), 14-bromoreticulatol (21), and 3-bromosecofascaplysins A (22) and B (23), along with known compounds: fascaplysin (1), reticulatine (4), 3-bromofascaplysin (6), and homofascaplysin C (14). Selected compounds were screened in a cell-based cytotoxicity assay with compounds 1, 6, and fascaplysin A (24) also screened in the NCI 60 cell line panel. A biogenetic pathway for the brominated fascaplysins and brominated related alkaloids is proposed and discussed.
Assuntos
Alcaloides , Indóis , Poríferos/química , Urocordados/química , Alcaloides/química , Alcaloides/isolamento & purificação , Alcaloides/farmacologia , Animais , Ensaios de Seleção de Medicamentos Antitumorais , Fiji , Humanos , Hidrocarbonetos Bromados/química , Hidrocarbonetos Bromados/isolamento & purificação , Hidrocarbonetos Bromados/farmacologia , Indóis/química , Indóis/isolamento & purificação , Indóis/farmacologia , Indonésia , Concentração Inibidora 50 , Estrutura Molecular , Ressonância Magnética Nuclear Biomolecular , Células Tumorais CultivadasRESUMO
A new-generation porcine valve fixed in glutaraldehyde at zero pressure and mounted on an acetal copolymer flexible stent was inserted in 97 patients between August 1983 and October 1986. The mean age of the patients was 51 years (range 10 to 76) and eight were under the age of 20 years. There were 57 mitral, 33 aortic, and 10 tricuspid valve replacements. Concomitant coronary artery bypass grafting was performed in 9% of patients, 40% underwent multiple valve operations, and in 40% the procedure was a reoperation. Mean follow-up was 26 months (range 12 to 49) and was 99% complete. There were no examples of primary tissue failure, and only to reoperations have been undertaken for infective endocarditis alone. The early mortality rate was 8.2% and the late mortality rate, 12.1%. Four late deaths were valve related (two caused by infective endocarditis and two by embolism). The actuarial 3-year survival rate was 70%, freedom from infective endocarditis 879%, freedom from embolism 87%, freedom from reoperation 90%, and freedom from valve-related complications 77%. All but three surviving patients were in New York Heart Association class I or II. Doppler echocardiography, performed in 62 of 76 survivors, showed thin and mobile leaflets in all patients and trivial or mild regurgitation in four (6%). The mean gradient across the Medtronic Intact valves (Medtronic Blood Systems Inc., Minneapolis, Minn.) in the aortic position was 17 +/- 5.2 mm Hg, in the mitral position 3.8 +/- 1.33 mm Hg, and in the tricuspid position 4.1 +/- 1.14 mm Hg. We conclude that early results with the Intact valve are encouraging.
